PTC Therapeutics (PTCT) stock on watch as company receives FDA approval for gene therapy Kebilidi for AADC deficiency. Read ...

PTC Therapeutics (PTCT) announced that the FDA accelerated approval of its gene therapy for the treatment of AADC deficiency, the first-ever ...

Vishay has introduced an automotive-rated series of positive temperature coefficient (PTC) in-rush current thermistors.

Joseph Schwartz, an analyst from Leerink Partners, reiterated the Hold rating on PTC Therapeutics (PTCT – Research Report). The ...

Nov 6 (Reuters) - Industrial software maker PTC (PTC.O), opens new tab forecast first-quarter revenue below estimates on Wednesday, signaling continued weakness in demand for its industrial design ...

PTC (NASDAQ: PTC) today announced that its Board of Directors has authorized the repurchase of up to $2 billion worth of PTC ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

PTC's SaaS transition is expected to enhance long-term cash flows but may cause near-term valuation contractions and revenue volatility. Despite strong operational performance and industry ...

This collaboration will integrate Configit's Configuration Lifecycle Management (CLM) solutions with PTC's Product Lifecycle Management (PLM) systems, offering a comprehensive and cohesive ...

In the latest quarter, 6 analysts provided ratings for PTC PTC, showcasing a mix of bullish and bearish perspectives. The table below provides a concise overview of recent ratings by analysts ...